Friday, December 13, 2013
By Eric Russell firstname.lastname@example.org
(Continued from page 1)
Ameridose Sterile Admixing Services in Westborough, Mass. Officials said Wednesday the pharmacy agreed to be shut down for state and federal inspection.
Ameridose has 30 days to surrender its license in Maine. Pharmacy board Chairman Joe Bruno said he doesn't think there will be a huge impact if Ameridose no longer does business in Maine. "There are other companies out there," he said.
State Rep. Sharon Treat, D-Hallowell, attended Thursday's meeting of the pharmacy board and said she nearly missed action on Ameridose and New England Compounding Center because the board does not identify names or organizations during complaint hearings.
Each complaint is assigned a number, and board members discuss the facts of each complaint, but all identifying information is withheld.
Bruno said that's standard practice, and information about the companies is made public only after action is taken. After the meeting, Bruno confirmed the action that was taken regarding Ameridose and New England Compounding Center.
Treat, who serves on the Legislature's Insurance and Financial Affairs Committee, said what has happened in Massachusetts should prompt policymakers here to look at regulation of compounding pharmacies.
Maine does not have facilities that do high-volume compounding -- mixing of pharmaceuticals. Compounding is done here on a case-by-case basis, as outlined in state statute.
Treat said Maine should be sure that statute is being followed.
"What we've seen in Massachusetts suggests that there hasn't been a lot of accountability in this area," she said. "We should be asking if there is adequate enforcement of these rules."
Staff Writer Eric Russell can be contacted at 791-6344 or at: